Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer?

Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer?

Introduction: The loss of brain cholinergic activity is a key phenomenon in the biochemistry of Alzheimer's Disease (AD). Due to the specific biosynthesis of Acetylcholinesterase (AChE) of cholinergic neurons, the enzyme has been proposed as a potential biochemical marker of cholinergic act...

Full description

Bibliographic Details
Main Authors:	Sedigheh Bakhtiari, Nahid Beladi Moghadam, Marjan Ehsani, Hamed Mortazavi, Siamak Sabour, Mahin Bakhshi
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2017-01-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	cholinesterase dementia exploring fluid biomarker
Online Access:	https://jcdr.net/articles/PDF/9192/21715_F(DK)_PF1(DK_NE)_PFA(DK)_PF2(NE_DK).pdf

Similar Items

Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis
by: Dominik Glinz, et al.
Published: (2019-06-01)

Dementia post-radiotherapy: improvement with acetylcholinesterase inhibitor A case report
by: Antonio Eduardo Damin, et al.

CHOLINESTERASE INHIBITORS IN THE TREATMENT OF DEMENTIA ALZHEIMER’S
by: Prameidya Primaniar S
Published: (2013-03-01)

Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders
by: Giovanni B Frisoni, et al.
Published: (2021-08-01)

Atypical Presentation of Acetylcholinesterase Inhibitor-Induced Diarrhea in Older Adults with Cognitive Decline: An Aspect not to be Underestimated
by: Raffaele Pagliuca, et al.
Published: (2023-03-01)

Alzheimer’s disease: A Threat to mankind
by: Poorti Pandey, et al.
Published: (2011-12-01)

Systematic Review of Cholinesterase Inhibitors on Cognition and Behavioral Symptoms in Patients of Chinese Descent with Alzheimer’s Disease, Vascular Dementia, or Mixed Dementia
by: Ka-Chun Leung, et al.
Published: (2017-08-01)

The acetylcholinesterase as indicative of intoxication for pesticide in farmers of conventional and organic cultivation
by: H. H. F. Alves, et al.
Published: (2020-08-01)

Ligand-based pharmacophore modeling to identify plant-derived acetylcholinesterase inhibitor natural compounds in Alzheimer’s disease
by: saeed pirmoradi
Published: (2023-07-01)

Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer’s disease dispensed by the Brazilian public health system – 2008 to 2014: a nation-wide analysis
by: Flávia Silva de Moraes, et al.

Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer’s Disease and Other Dementias
by: Taim Muayqil, et al.
Published: (2012-11-01)

Computational Approaches to Evaluate the Acetylcholinesterase Binding Interaction with Taxifolin for the Management of Alzheimer’s Disease
by: Varish Ahmad, et al.
Published: (2024-01-01)

Biophenols of mints: Antioxidant, acetylcholinesterase, butyrylcholinesterase and histone deacetylase inhibition activities targeting Alzheimer’s disease treatment
by: Doaa M. Hanafy, et al.
Published: (2017-06-01)

Acetylcholinesterase: Old Questions and New Developments
by: Karl eTsim, et al.
Published: (2013-01-01)

Preventive Role of Indian Black Pepper in Animal Models of Alzheimer’s Disease
by: Lokraj Subedee, et al.
Published: (2015-04-01)

BODIPY-labelled acetylcholinesterase reactivators can be encapsulated into ferritin nanovehicles for enhanced bioavailability in the CNS
by: Eliska Prchalova, et al.
Published: (2023-11-01)

Effect of Gallic Acid on Reactivation of Acetylcholinesterase and Butyrylcholinesterase Inhibited by Diazinon in Vitro and in Vivo
by: Farzaneh Sadat Motafeghi, et al.
Published: (2020-10-01)

Acetylcholinesterase in Biofouling Species: Characterization and Mode of Action of Cyanobacteria-Derived Antifouling Agents
by: Joana R. Almeida, et al.
Published: (2015-07-01)

Effects of Standard Treatment Alone Versus Standard Treatment plus Plasmapheresis on the Levels of Serum Pseudocholinesterase and Erythrocyte Acetylcholinesterase in Critically Patients with Organophosphate Poisoning: Randomized Controlled, Open-label, Clinical Trial
by: Muhammet Güven, et al.
Published: (2023-10-01)

Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant
by: Gabriela Alves de Souza, et al.
Published: (2019-01-01)

Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
by: I. Caroline Vaaland, et al.
Published: (2023-12-01)

Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
by: Devika Jadhav, et al.
Published: (2024-01-01)

Treatment of vascular dementia Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
by: Sonia Maria Dozzi Brucki, et al.

Can Activation of Acetylcholinesterase by β-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?
by: Irina V. Zueva, et al.
Published: (2023-11-01)

Treatment of Visual Hallucinations in Schizophrenia by Acetylcholinesterase Inhibitors: a case report
by: Ali Mohammadi, et al.
Published: (2011-10-01)

A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE)
by: Tereza Cristina Santos Evangelista, et al.
Published: (2022-12-01)

A Smartphone Camera Colorimetric Assay of Acetylcholinesterase and Butyrylcholinesterase Activity
by: Miroslav Pohanka, et al.
Published: (2021-03-01)

Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management
by: Luis Agüera-Ortiz, et al.
Published: (2021-02-01)

Dementia patients have greater anti-cholinergic drug burden on discharge from hospital: A multicentre cross-sectional study
by: J. Randall, et al.
Published: (2021-04-01)

Association of cognitive enhancers and incident seizure risk in dementia: a population-based study
by: Junghee Ha, et al.
Published: (2022-06-01)

Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM)
by: Aina Soler, et al.
Published: (2019-04-01)

Effect of donepezil for dementia prevention in Parkinson's disease with severe hyposmia (The DASH-PD study): A randomized long-term placebo-controlled trial
by: Toru Baba, et al.
Published: (2022-09-01)

Impact of Sucrose as Osmolyte on Molecular Dynamics of Mouse Acetylcholinesterase
by: Sofya V. Lushchekina, et al.
Published: (2020-12-01)

Isolation, characterization, and ELISA applications of alkaline phosphatase and acetylcholinesterase from Moniezia expansa
by: Doaa A. Darwish, et al.
Published: (2024-01-01)

Acetylcholinesterase enzyme inhibitor activity of some novel pyrazinamide condensed 1,2,3,4-tetrahydropyrimidines
by: Karthikeyan Elumalai, et al.
Published: (2015-03-01)

Acetylcholinesterase- and Butyrylcholinesterase-Based Biosensors for the Detection of Quaternary Ammonium Biocides in Food Industry
by: Lynn Mouawad, et al.
Published: (2023-12-01)

Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection
by: Shoaib Shoaib, et al.
Published: (2023-02-01)

The efficacy of pharmacological interventions to improve cognitive and behavior symptoms in people with dementia: A systematic review and meta‐analysis
by: Wisdom K. Takramah, et al.
Published: (2022-11-01)

CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia
by: Nathan Herrmann, et al.
Published: (2022-01-01)

Editorial: Cognitive Impairment: Therapy Momentum in the Continuum of Life
by: Artemissia-Phoebe Nifli, et al.
Published: (2021-01-01)